These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 15445969)
1. Development of phentermine, an appetite-control drug. SEHNERT KW Clin Med (Northfield); 1963 Feb; 70():400-3. PubMed ID: 15445969 [No Abstract] [Full Text] [Related]
2. Phentermine: an appetite-suppressant amphetamine classified as a narcotic in France. Is a combination with topiramate on the horizon? Prescrire Int; 2012 Sep; 21(130):209. PubMed ID: 23016252 [TBL] [Abstract][Full Text] [Related]
3. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease. Bays H Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765 [TBL] [Abstract][Full Text] [Related]
4. A COMPARISON OF THE APPETITE SUPPRESSING PROPERTIES OF DEXAMPHETAMINE AND PHENTERMINE. SEATON DA; ROSE K; DUNCAN LJ Scott Med J; 1964 Nov; 9():482-5. PubMed ID: 14231545 [No Abstract] [Full Text] [Related]
5. Anorectic medications in the treatment of obesity. Brune DB Arch Fam Med; 1994 Feb; 3(2):116. PubMed ID: 7994431 [No Abstract] [Full Text] [Related]
6. Appetite-suppressant drugs and primary pulmonary hypertension. Schembre DB; Boynton KK N Engl J Med; 1997 Feb; 336(7):510-1; author reply 512-3. PubMed ID: 9019649 [No Abstract] [Full Text] [Related]
7. Valvular heart disease associated with fenfluramine-phentermine. Spitzer WO N Engl J Med; 1997 Dec; 337(24):1774-5; author reply 1775-6. PubMed ID: 9411251 [No Abstract] [Full Text] [Related]
8. New antiobesity agents: lorcaserin (Belviq) and phentermine/topiramate ER (Qsymia). Shyh G; Cheng-Lai A Cardiol Rev; 2014; 22(1):43-50. PubMed ID: 24304809 [TBL] [Abstract][Full Text] [Related]
9. The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs. Khan MA; Herzog CA; St Peter JV; Hartley GG; Madlon-Kay R; Dick CD; Asinger RW; Vessey JT N Engl J Med; 1998 Sep; 339(11):713-8. PubMed ID: 9731086 [TBL] [Abstract][Full Text] [Related]
10. [Clinical experience with the use of phenyltert-butylamine (phentermine) as an appetite depressant in the treatment of obesity]. Lobato DS; da Silveira DD Hospital (Rio J); 1966 Nov; 70(5):1343-50. PubMed ID: 5301950 [No Abstract] [Full Text] [Related]
12. Synthesis of Phentermine and its Derivatives. Upadhyaya K; Shukla S; Meena BP; Dwivedi J Curr Org Synth; 2024; 21(5):583-594. PubMed ID: 37259208 [TBL] [Abstract][Full Text] [Related]
13. Treatment of obesity with phenmetrazine hydrochloride, a new anorexiant. RESSLER C J Am Med Assoc; 1957 Sep; 165(2):135-8. PubMed ID: 13462759 [No Abstract] [Full Text] [Related]
14. Clinical studies of a new anorexiant. NAUMANN DE Appl Ther; 1962 Jun; 4():550-1. PubMed ID: 14478580 [No Abstract] [Full Text] [Related]
15. A new nonamphetamine anorectic agent. FREED SC; HAYS EE Am J Med Sci; 1959 Jul; 238(1):55-9. PubMed ID: 13661175 [No Abstract] [Full Text] [Related]
16. A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation. Jick H; Vasilakis C; Weinrauch LA; Meier CR; Jick SS; Derby LE N Engl J Med; 1998 Sep; 339(11):719-24. PubMed ID: 9731087 [TBL] [Abstract][Full Text] [Related]
17. Study of phendimetrazine bitartrate as an appetite suppressant in relation to dosage, weight loss and side effects. LE RICHE WH; VAN BELLE G Can Med Assoc J; 1962 Jul; 87(1):29-31. PubMed ID: 14463177 [No Abstract] [Full Text] [Related]